Foscarnet-induced penile ulceration by Torres, T. et al.
39
Foscarnet-induced penile ulceration
Acta Dermatoven APA Vol 20, 2011, No 1
C a s e  r e p o r t
Foscarnet-induced 
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Foscarnet is used to treat infections with herpes viruses, including drug-resistant cytomegalovirus 
(CMV) and infections with herpes viruses 1 and 2 (HSV-1 and HSV-2). There are some reports of 
intravenous foscarnet-induced penile and vulvar ulceration. The authors report a case of severe 
penile ulcers after the initiation of intravenous foscarnet therapy.
S U M M A R Y
Foscarnet is a pyrophosphate analogue that inhib-
its viral DNA polymerases including reverse trancrip-
WDVHRIKXPDQLPPQXQRGHÀFLHQF\YLUXVW\SH,WLV
used to treat infections with herpes viruses, including 
drug-resistant cytomegalovirus (CMV), particularly 
LQ&09UHWLQLWLVDQGLQIHFWLRQVZLWKDQG+69
DQG+697KHUH DUH VRPH UHSRUWV RI LQWUDYHQRXV
foscarnet-induced penile and vulvar ulcerations (1, 2).
The authors report a case of a 32-year-old man with 
DFTXLUHGLPPXQHGHÀFLHQF\V\QGURPHZKRVWDUWHGLQ-
travenous foscarnet (90 mg/kg/bid) for ganciclovir-
resistant cytomegalovirus hepatitis. Ten days after 
initiating foscarnet, he developed multiple, painful 
penile ulcers (Fig. 1). Physical examination revealed 
an uncircumcised man with multiple irregular, tender, 
nonindurated ulcerations with serous exudate, located 
on the periurethral area, glans, and penile shaft. The 
surrounding skin was normal. Inguinal lymphade-
nopathy was absent. Screening for syphilis (serology), 
fungi (potassium hydroxide preparation test), and vi-
UXVHV7]DQFNSUHSDUDWLRQDQGSRO\PHUDVHFKDLQUHDF-
tion test for herpes simplex virus) were all negative. A 
FXWDQHRXVELRSV\ZDV UHIXVHG3HQLOHFDWKHWHUL]DWLRQ
was performed and foscarnet was discontinued after 
hepatic improvement. Improvement in the ulceration 
ZDVQRWHGDIWHURQHZHHN)LJDQGVLJQLÀFDQWKHDO-
ing one month later.
Foscarnet is used to treat herpes viruses, including 
drug-resistant cytomegalovirus (CMV), particularly 
&09 UHWLQLWLV DQG LQIHFWLRQVZLWK  DQG  +69
DQG+69)RVFDUQHWFDQDOVREHXVHGWRWUHDW+,9
patients as part of salvage therapy. Nephrotoxicity is 
a major side effect associated with foscarnet therapy. 
Additional adverse effects include hypocalcemia, ane-
mia, thrombophlebitis of the peripheral veins, and 
mild elevation of liver function tests.
There are some reports of intravenous foscarnet-
induced penile and vulvar ulcerations (1, 2). The cause 
of the ulcerations is unknown. Although clinically the 
XOFHUVFDQUHVHPEOHDÀ[HGGUXJHUXSWLRQWKHELRSV\
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ÀQGLQJV GR QRW VXSSRUW WKLV GLDJQRVLV DQG WHQG WR
support an acute dermatitis (3). Topical preparations 
RIIRVFDUQHWFUHDPKDYHEHHQIRXQGWRLQGXFHVH-
vere irritant dermatitis, particularly in the subprepu-
tial space in uncircumcised men, while topical prepa-
UDWLRQVRIWRKDYHEHHQEHWWHUWROHUDWHG
$SSUR[LPDWHO\RIWKHGUXJLVH[FUHWHGXQFKDQJHG
in the urine and may be retained in the subpreputial 
space after urination. An irritant dermatitis second-
ary to cutaneous contact with foscarnet in the urine 
seems plausible, mainly because all reports of ulcer-
ation have occurred early on in treatment when high 
dose regimens are used. Moreover, because of foscar-
net nephrotoxicity, good hydration during therapy is 
recommended, increasing the frequency of urination 
and thus increasing the chance of genital ulceration. 
Good personal hygiene, including washing the geni-
tals after urination, is recommended to reduce the oc-
currence of this side effect (5).
Although the patient refused a biopsy, the devel-
opment of the ulcers after starting foscarnet and the 
improvement with the cessation of the antiviral ther-
apy allows us to assume that this is another case of 
foscarnet-induced genital ulcers.
With the increasing number of patients with re-
sistant herpes virus infections being treated with 
foscarnet, it is essential to be aware of this potential 
complication.
Figure 1. Irregular, tender, nonindurated ulcer-
ation, located on the periurethral area, gland, 
and penile shaft.
Figure 2. Ulceration improvement after penile 
catheterization and discontinuation of foscarnet.
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